PureTech affiliate Sonde Health names David Liu as CEO

PureTech Health

154.80p

12:40 24/12/24

-1.02%

-1.60p

Clinical stage biotechnology company PureTech Health announced on Thursday that its affiliate Sonde Health had appointed David Liu as chief executive officer and a member of its board of directors.

FTSE 250

20,571.51

13:00 24/12/24

n/a

FTSE 350

4,491.87

12:54 24/12/24

n/a

FTSE All-Share

4,449.61

13:14 24/12/24

n/a

Pharmaceuticals & Biotechnology

20,055.90

12:54 24/12/24

0.25%

50.73

PureTech noted that Liu, who spent more than a decade pioneering novel online products with America Online, had served in executive roles across multiple enterprises targeting international markets, including Quartet, a growth-stage enterprise healthcare technology company, and Knewton, where he helped to build a leading global education technology company.

The FTSE 250 firm's chief innovation officer Eric Elenko said: "David's experience guiding companies through significant growth positions him as a valuable addition to Sonde's team as they pioneer a new approach to healthcare."

As of 0830 BST, PureTech shares had inched back 0.39% to 254p.